Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 6/2022

14-03-2022 | Correction

Correction to: Implementation barriers to integrating exercise as medicine in oncology: an ecological scoping review

Authors: Mary A. Kennedy, Sara Bayes, Robert U. Newton, Yvonne Zissiadis, Nigel A. Spry, Dennis R. Taaffe, Nicolas H. Hart, Daniel A. Galvão

Published in: Journal of Cancer Survivorship | Issue 6/2022

Login to get access

Excerpt

Correction to: Journal of Cancer Survivorship …
Metadata
Title
Correction to: Implementation barriers to integrating exercise as medicine in oncology: an ecological scoping review
Authors
Mary A. Kennedy
Sara Bayes
Robert U. Newton
Yvonne Zissiadis
Nigel A. Spry
Dennis R. Taaffe
Nicolas H. Hart
Daniel A. Galvão
Publication date
14-03-2022
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 6/2022
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01116-5

Other articles of this Issue 6/2022

Journal of Cancer Survivorship 6/2022 Go to the issue

Review

Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines

Review

Identifying the unmet supportive care needs of people affected by kidney cancer: a systematic review

OriginalPaper

Association between aspects of social support and health-related quality of life domains among African American and White breast cancer survivors

Review

Large-scale North American cancer survivorship surveys: 2011–2019 update

OriginalPaper

Disparities in healthcare utilization and access by length of cancer survivorship among population-based female cancer survivors

OriginalPaper

Physiological and psychosocial correlates of cancer-related fatigue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits